Impact of a restrictive antimicrobial policy on the process and timing of antimicrobial administration

Journal of Hospital Medicine

Volumn 5, Issue 1, 2010, Pages

  Winters, Bradford D ^a   Thiemann, David R ^b   Brotman, Daniel J ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antimicrobial; Infection control; Process of care

Indexed keywords

ACICLOVIR; AMPHOTERICIN; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFALEXIN; CEFAZOLIN; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERTAPENEM; FLUCONAZOLE; GATIFLOXACIN; GENTAMICIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; OXACILLIN; SULTAMICILLIN; TOBRAMYCIN; VANCOMYCIN;

AGE DISTRIBUTION; ANTIMICROBIAL THERAPY; ARTICLE; CONTROLLED STUDY; DRUG APPROVAL; DRUG MONITORING; DRUG UTILIZATION; EVENING DOSAGE; HEALTH CARE POLICY; MORNING DOSAGE; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; THERAPY DELAY; UTILIZATION REVIEW;

ANTI-INFECTIVE AGENTS; COHORT STUDIES; CONFIDENCE INTERVALS; HOSPITALS; INFECTION CONTROL; MEDICAL ORDER ENTRY SYSTEMS; ODDS RATIO; ORGANIZATIONAL POLICY; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 74949112654     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.561     Document Type: Article

References (27)

1. Fishman N. Antimicrobial stewardship. Am J Med. 2006;119:S53-S61.
2. Paterson DL. Restrictive antibiotic policies are appropriate in intensive care units. Crit Care Med. 2003;31:S25-S28.
3. White AC, Atmar RL, Wilson J, et al. Effects of requiring prior authorization for selected anti-microbials: expenditures, susceptibilities and clinical outcomes. Clin Infect Dis. 1997;25:230-239.
4. Rahal JJ, Urban C, Horn D, et al. Class restriction of cephalosporin use to control total cephaslosporin resistance in nosocomial Klebsiella. JAMA. 1998;280:1233-1237.
5. Gruson D, Hibert G, Vargas F, et al. Rotation and restricted use of antibiotics in a medical intensive care unit: impact on the incidence of ventilator associated pneumonia caused by antibiotic resistant Gramnegative bacteremia. Am J Respir Crit Care Med. 2001;63(3 Pt 1):837-843.
6. Raymond DP, Pelletier SJ, Crabtree TD, et al. Impact of rotation of empiric antibiotic schedules on infectious mortality in an intensive care unit. CCM. 2001;29:1101-1108.
7. Zillich AJ, Sutherland JM, Wilson SJ, et al. Antimicrobial use control measures to prevent and control antimicrobial resistance in US hospitals. Infect Control Hosp Epidemiol. 2006;27:1088-1095.
8. Coleman RW, Rodondi LC, Kaubisch S, Granzella NB, O'Hanley PD. Costeffectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med. 1991;90:439-444.
9. John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis. 1997;24:471-485.
10. Owens RC Jr, Ambrose PG. Antimicrobial stewardship and the role of pharmacokinetics-pharmacodynamics in the modern antibiotic era. Diagn Microbiol Infect Dis. 2007;57(3 Suppl.):77S-83S.
11. Schiff GD, Wisniewski M, Bult J, Parada JP, Aggarwal H, Schwartz DN. Improving inpatient antibiotic prescribing: insights from participation in a national collaborative. Jt Comm J Qual Improv. 2001;27:387-402.
12. Wenzel RP, Edmond MB. Managing antibiotic resistance. N Engl J Med. 2000;343:1961-1963.
13. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005;18(4):638-656.
14. Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, Holmes A, Ramsay C, Taylor E, Wilcox M, Wiffen P. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2005;4:CD003543.
15. Metjian TA, Prasad PA, Kogon A, Coffin SE, Zaoutis TE. Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital. Pediatr Infect Dis J. 2008;27(2):106-111.
16. Pakyz AL. The utility of hospital antibiograms as tools for guiding empiric therapy and tracking resistance. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotheray. 2007;27(9):1306-1312.
17. Wilton P, Smith R, Coast J, Millar M. Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness. J Health Serv Res Policy. 2002;7(2):111-117.
18. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159-177.
19. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee. Management of Multi-Drug Reistsant Organisms in Healthcare Settings: 2006. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ar/MDROGuideline2006.pdf. Accessed May 19, 2008.
20. Kreger BE, Craven DE, McCabe WR. Gram-negative bacteremia. IV Reevaluation of clinical features and treatment in 612 patients. Am J Med. 1980;68:344-355.
21. Kreger BE, Craven DE, Carling PC, McCabe WR. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med. 1980;68:332-343.
22. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462-474.
23. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med. 1996;22:387-394.
24. Rello J, Gallego M, Mariscal D, Sonora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156:196-200.
25. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 1997;111:676-685.
26. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator associated pneumonia. Chest. 1998;113:412-420.
27. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146-155.